BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Joshi CR, Labhasetwar V, Ghorpade A. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery. J Neuroimmune Pharmacol 2017;12:51-83. [PMID: 28160121 DOI: 10.1007/s11481-016-9724-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Ortega-Pineda L, Sunyecz A, Salazar-Puerta AI, Rincon-Benavides MA, Alzate-Correa D, Anaparthi AL, Guilfoyle E, Mezache L, Struckman HL, Duarte-Sanmiguel S, Deng B, McComb DW, Dodd DJ, Lawrence WR, Moore J, Zhang J, Reátegui E, Veeraraghavan R, Nelson MT, Gallego-Perez D, Higuita-Castro N. Designer Extracellular Vesicles Modulate Pro-Neuronal Cell Responses and Improve Intracranial Retention. Adv Healthc Mater 2022;11:e2100805. [PMID: 35014204 DOI: 10.1002/adhm.202100805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Robison AJ, Nestler EJ. ΔFOSB: A Potentially Druggable Master Orchestrator of Activity-Dependent Gene Expression. ACS Chem Neurosci 2022;13:296-307. [PMID: 35020364 DOI: 10.1021/acschemneuro.1c00723] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
3 Coorey BA, Gold WA. Breaking Boundaries in the Brain-Advances in Editing Tools for Neurogenetic Disorders. Front Genome Ed 2021;3:623519. [PMID: 34713252 DOI: 10.3389/fgeed.2021.623519] [Reference Citation Analysis]
4 Khayamabed R, Rezaie N, Poorgolizadeh E, Homayouni Moghadam F, Dorminani K, Nasr Esfahani MH; Department of Biology, ACECR Institute of Higher Education, Isfahan, Iran, Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran, Department of Biology, ACECR Institute of Higher Education, Isfahan, Iran, Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran, Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran, Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran. Efficient Modified-mRNA Transfection in Neural Stem Cells. Physiol Pharmacol 2021;0:0-0. [DOI: 10.52547/phypha.27.1.5] [Reference Citation Analysis]
5 Letko Khait N, Ho E, Shoichet MS. Wielding the Double‐Edged Sword of Inflammation: Building Biomaterial‐Based Strategies for Immunomodulation in Ischemic Stroke Treatment. Adv Funct Mater 2021;31:2010674. [DOI: 10.1002/adfm.202010674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Moradi SZ, Jalili F, Farhadian N, Joshi T, Wang M, Zou L, Cao H, Farzaei MH, Xiao J. Polyphenols and neurodegenerative diseases: focus on neuronal regeneration. Crit Rev Food Sci Nutr 2021;:1-16. [PMID: 33393375 DOI: 10.1080/10408398.2020.1865870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
7 Dhas N, Mehta T, Sharma S, Garkal A, Yadav D, Hariharan K, Shamjetshabam B, Khot S, Kudarha R, Bangar P, Arbade G, Kalyankar P. Intranasal gene therapy for the treatment of neurological disorders. Direct Nose-to-Brain Drug Delivery 2021. [DOI: 10.1016/b978-0-12-822522-6.00017-5] [Reference Citation Analysis]
8 Gantenbein B, Tang S, Guerrero J, Higuita-Castro N, Salazar-Puerta AI, Croft AS, Gazdhar A, Purmessur D. Non-viral Gene Delivery Methods for Bone and Joints. Front Bioeng Biotechnol 2020;8:598466. [PMID: 33330428 DOI: 10.3389/fbioe.2020.598466] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
9 Iqubal A, Iqubal MK, Khan A, Ali J, Baboota S, Haque SE. Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective. CGT 2020;20:184-94. [DOI: 10.2174/1566523220999200716111502] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
10 Martier R, Konstantinova P. Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock. Front Neurosci 2020;14:580179. [PMID: 33071748 DOI: 10.3389/fnins.2020.580179] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
11 Dulman RS, Wandling GM, Pandey SC. Epigenetic mechanisms underlying pathobiology of alcohol use disorder. Curr Pathobiol Rep 2020;8:61-73. [PMID: 33747641 DOI: 10.1007/s40139-020-00210-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Proulx J, Joshi C, Vijayaraghavalu S, Saraswathy M, Labhasetwar V, Ghorpade A, Borgmann K. Arginine-Modified Polymers Facilitate Poly (Lactide-Co-Glycolide)-Based Nanoparticle Gene Delivery to Primary Human Astrocytes. Int J Nanomedicine 2020;15:3639-47. [PMID: 32547019 DOI: 10.2147/IJN.S250865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ojeda-Hernández DD, Canales-Aguirre AA, Matias-Guiu J, Gomez-Pinedo U, Mateos-Díaz JC. Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System. Front Bioeng Biotechnol 2020;8:389. [PMID: 32432095 DOI: 10.3389/fbioe.2020.00389] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 26.0] [Reference Citation Analysis]
14 Ghali GZ, Ghali MGZ. β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma. Mol Biol Rep 2020;47:4631-50. [PMID: 32303958 DOI: 10.1007/s11033-020-05427-1] [Reference Citation Analysis]
15 Lockowandt M, Günther DM, Quintino L, Breger LS, Isaksson C, Lundberg C. Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector. J Neurosci Methods 2020;336:108542. [PMID: 32017975 DOI: 10.1016/j.jneumeth.2019.108542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rosenberg JB, Chen A, Kaminsky SM, Crystal RG, Sondhi D. Advances in the Treatment of Neuronal Ceroid Lipofuscinosis. Expert Opin Orphan Drugs 2019;7:473-500. [PMID: 33365208 DOI: 10.1080/21678707.2019.1684258] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
17 Deng L, Zhang F, Wu Y, Luo J, Mao X, Long L, Gou M, Yang L, Deng DYB. RGD-Modified Nanocarrier-Mediated Targeted Delivery of HIF-1α-AA Plasmid DNA to Cerebrovascular Endothelial Cells for Ischemic Stroke Treatment. ACS Biomater Sci Eng 2019;5:6254-64. [PMID: 33405532 DOI: 10.1021/acsbiomaterials.9b01362] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
18 Pena SA, Iyengar R, Eshraghi RS, Bencie N, Mittal J, Aljohani A, Mittal R, Eshraghi AA. Gene therapy for neurological disorders: challenges and recent advancements. Journal of Drug Targeting 2020;28:111-28. [DOI: 10.1080/1061186x.2019.1630415] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
19 Barbullushi K, Abati E, Rizzo F, Bresolin N, Comi GP, Corti S. Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art. Mol Neurobiol 2019;56:6460-71. [DOI: 10.1007/s12035-019-1533-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
20 Araújo RV, Santos SDS, Igne Ferreira E, Giarolla J. New Advances in General Biomedical Applications of PAMAM Dendrimers. Molecules 2018;23:E2849. [PMID: 30400134 DOI: 10.3390/molecules23112849] [Cited by in Crossref: 124] [Cited by in F6Publishing: 134] [Article Influence: 31.0] [Reference Citation Analysis]
21 Roovers J, De Jonghe P, Weckhuysen S. The therapeutic potential of RNA regulation in neurological disorders. Expert Opin Ther Targets 2018;22:1017-28. [PMID: 30372655 DOI: 10.1080/14728222.2018.1542429] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
22 Joshi CR, Raghavan V, Vijayaraghavalu S, Gao Y, Saraswathy M, Labhasetwar V, Ghorpade A. Reaching for the Stars in the Brain: Polymer-Mediated Gene Delivery to Human Astrocytes. Mol Ther Nucleic Acids 2018;12:645-57. [PMID: 30081235 DOI: 10.1016/j.omtn.2018.06.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
23 Abdallah K, Nadeau F, Bergeron F, Blouin S, Blais V, Bradbury KM, Lavoie CL, Parent JL, Gendron L. Adeno-associated virus 2/9 delivery of Cre recombinase in mouse primary afferents. Sci Rep 2018;8:7321. [PMID: 29743652 DOI: 10.1038/s41598-018-25626-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Pardieck J, Sakiyama-Elbert S. Genome engineering for CNS injury and disease. Curr Opin Biotechnol 2018;52:89-94. [PMID: 29597076 DOI: 10.1016/j.copbio.2018.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
25 Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, Pey E, Zhao L, Ricart Arbona RJ, Monette S, Dyke JP, Ballon DJ, Kaminsky SM, Sondhi D, Petsko GA, Paul SM, Crystal RG. AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. Hum Gene Ther Clin Dev 2018;29:24-47. [PMID: 29409358 DOI: 10.1089/humc.2017.231] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 14.0] [Reference Citation Analysis]
26 Wilson RC, Gilbert LA. The Promise and Challenge of In Vivo Delivery for Genome Therapeutics. ACS Chem Biol 2018;13:376-82. [PMID: 29019396 DOI: 10.1021/acschembio.7b00680] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 11.3] [Reference Citation Analysis]
27 Rudd PA, Herrero LJ. Viruses: Friends and Foes. Cartilage Repair and Regeneration 2018. [DOI: 10.5772/intechopen.71071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Tan VTY, Mockett BG, Ohline SM, Parfitt KD, Wicky HE, Peppercorn K, Schoderboeck L, Yahaya MFB, Tate WP, Hughes SM, Abraham WC. Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease. Mol Brain 2018;11:7. [PMID: 29426354 DOI: 10.1186/s13041-018-0348-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
29 Wu JY, Ji AL, Wang ZX, Qiang GH, Qu Z, Wu JH, Jiang CP. Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo. Sci Rep 2018;8:2471. [PMID: 29410409 DOI: 10.1038/s41598-018-20505-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 11.5] [Reference Citation Analysis]
30 Boone DR, Leek JM, Falduto MT, Torres KEO, Sell SL, Parsley MA, Cowart JC, Uchida T, Micci MA, DeWitt DS, Prough DS, Hellmich HL. Effects of AAV-mediated knockdown of nNOS and GPx-1 gene expression in rat hippocampus after traumatic brain injury. PLoS One 2017;12:e0185943. [PMID: 29016640 DOI: 10.1371/journal.pone.0185943] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
31 Borgmann K, Ghorpade A. Methamphetamine Augments Concurrent Astrocyte Mitochondrial Stress, Oxidative Burden, and Antioxidant Capacity: Tipping the Balance in HIV-Associated Neurodegeneration. Neurotox Res 2018;33:433-47. [PMID: 28993979 DOI: 10.1007/s12640-017-9812-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
32 Stamberger H, Weckhuysen S, De Jonghe P. STXBP1 as a therapeutic target for epileptic encephalopathy. Expert Opinion on Therapeutic Targets 2017;21:1027-36. [DOI: 10.1080/14728222.2017.1386175] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
33 Helmschrodt C, Höbel S, Schöniger S, Bauer A, Bonicelli J, Gringmuth M, Fietz SA, Aigner A, Richter A, Richter F. Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's Disease. Mol Ther Nucleic Acids 2017;9:57-68. [PMID: 29246324 DOI: 10.1016/j.omtn.2017.08.013] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 14.2] [Reference Citation Analysis]
34 Thuringer D, Solary E, Garrido C. The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease Treatment. Front Mol Neurosci 2017;10:246. [PMID: 28824376 DOI: 10.3389/fnmol.2017.00246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
35 Reynolds JL, Mahato RI. Nanomedicines for the Treatment of CNS Diseases. J Neuroimmune Pharmacol 2017;12:1-5. [PMID: 28150132 DOI: 10.1007/s11481-017-9725-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 5.4] [Reference Citation Analysis]